We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Albion Enterprise Vct Plc | LSE:AAEV | London | Ordinary Share | GB00B1G3LR35 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 119.50 | 118.00 | 121.00 | 119.50 | 119.50 | 119.50 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investors, Nec | 5.74M | 2.77M | 0.0274 | 43.61 | 120.55M |
TIDMAAEV
ALBION ENTERPRISE VCT PLC
LEI Code: 213800OVSRDHRJBMO720
Interim Management Statement
Introduction
I present Albion Enterprise VCT PLC (the "Company")'s interim management statement for the period from 1 April 2021 to 30 June 2021.
Performance and dividends
The Company's unaudited net asset value (NAV) on 30 June 2021 was GBP95.82 million or 127.93 pence per share (excluding treasury shares), an increase of 13.33 pence per share (11.6%) since 31 March 2021.
It was announced on 21 June 2021 that two companies within the portfolio were undergoing external fundraising processes. These fundraisings were both at significantly higher valuations to their original 31 March 2021 valuations. There have also been uplifts in several of our technology and healthcare investments due to strong trading performances which have also contributed to the excellent return for the period.
After accounting for the dividend of 2.87 pence per share to be paid on 31 August 2021 to shareholders on the register on 6 August 2021, the NAV is 125.06 pence per share.
Fundraising and share issues
During the period from 1 April 2021 to 30 June 2021, the Company issued the following new Ordinary shares of nominal value 1 penny per share under the Albion VCTs Prospectus Top Up Offers 2020/21:
Issue price per share (including costs of Net proceeds Date Number of shares issued issue) GBP'000 ------------- ----------------------- ------------------------ ------------ 9 April 2021 383,354 114.0p -- 115.2p 431 ------------- ----------------------- ------------------------ ------------
Portfolio
The following investments have been made during the period from 1 April 2021 to 30 June 2021:
New investments GBP000s Activity --------------- ------- ------------------------------------------------------ Gravitee TopCo Limited (T/A gravitee.io) 763 API management platform --------------- ------- ------------------------------------------------------ Digital therapeutics and decentralised clinical trials NuvoAir AB 649 for respiratory conditions --------------- ------- ------------------------------------------------------ Brytlyt Limited 310 A GPU database provider --------------- ------- ------------------------------------------------------ Accelex Technology Limited (T/A Data extraction and analytics technology for private Accelex) 265 capital markets --------------- ------- ------------------------------------------------------ Total new investments 1,987 --------------- ------- ------------------------------------------------------ Further investments GBP000s Activity ----------------- ------- -------------------------------------------------- A patient engagement and data capture platform for uMotif Limited 531 use in real world and observational research ----------------- ------- -------------------------------------------------- Panaseer Limited 269 Provider of cyber security services ----------------- ------- -------------------------------------------------- Abcodia Limited 34 Validation and discovery of serum biomarkers ----------------- ------- -------------------------------------------------- Total further investments 834 ----------------- ------- --------------------------------------------------
Top ten holdings (on 30 June 2021)
% of net Carrying value asset Investment GBP000 value Activity ------------- -------------- ----- ------------------------------------------------------------ Quantexa Limited 14,489 15.1% Network analytics platform to detect financial crime ------------- -------------- ----- ------------------------------------------------------------ Egress Software Technologies Limited 11,702 12.2% Encrypted email & file transfer service provider ------------- -------------- ----- ------------------------------------------------------------ Proveca Limited 6,133 6.4% Reformulation of paediatric medicines ------------- -------------- ----- ------------------------------------------------------------ A technology enabled service business in medical nutritional Oviva AG 3,630 3.8% therapy (MNT) ------------- -------------- ----- ------------------------------------------------------------ Radnor House School (TopCo) Limited 3,006 3.1% Independent school for children aged 3-18 ------------- -------------- ----- ------------------------------------------------------------ Phrasee Limited 2,142 2.2% AI platform that generates optimised marketing campaigns ------------- -------------- ----- ------------------------------------------------------------ The Evewell Group Operator and developer of women's health centres focusing Limited 2,043 2.1% on fertility. ------------- -------------- ----- ------------------------------------------------------------ Regenerco Renewable Energy Generator of renewable energy from roof top solar Limited 2,007 2.1% installations ------------- -------------- ----- ------------------------------------------------------------ Black Swan Data Limited 1,791 1.9% Predictive analytics for consumer brands ------------- -------------- ----- ------------------------------------------------------------ Healios 1,656 1.7% Provider of an online platform delivering family centric Limited psychological care primarily to children and adolescents ------------- -------------- ----- ------------------------------------------------------------
A full breakdown of the Company's portfolio can be found on the Company's webpage on the Manager's website at https://www.globenewswire.com/Tracker?data=VsfTzcwbyJxyH9lSUcKZxAp_ARO5bhk2FpmYgCowUl95xtUQnMw8j4LRlo-zYzIHdf__TcT6ANBf4djFbQ0SFK66PyvKPLSK57tsx4MPH_F7lp77qX-Q2FobcQxo-TzW www.albion.capital/funds/AAEV.
Share buy-backs
During the period from 1 April 2021 to 30 June 2021, the Company did not buy back any shares.
It remains the Board's policy to buy back shares in the market, subject to the overall constraint that such purchases are in the Company's interest, including the maintenance of sufficient resources for investment in existing and new portfolio companies and the continued payment of dividends to shareholders.
It is the Board's intention for such buy-backs to be at around a 5% discount to net asset value, so far as market conditions and liquidity permit.
Material events and transactions after the period end
After the period end, the Company had the following material investment transaction:
-- Investment of GBP423,000 in an existing portfolio company, The Evewell Group Limited, an operator and developer of women's health centres focusing on fertility.
Other than as described above, there have been no material events or transactions during the quarter and to the date of this announcement.
Further information
Further information regarding historic and current financial performance and other useful shareholder information can be found on the Company's webpage on the Manager's website at https://www.globenewswire.com/Tracker?data=VsfTzcwbyJxyH9lSUcKZxAp_ARO5bhk2FpmYgCowUl_aWsgpv2c-Fv-eX2au_rap_Zgppbm9UB2kAIXXnktf6RSLhHe4GrXjBWXTZPhpCnAwb2spGiHqctpcOzcyI6Vm www.albion.capital/funds/AAEV.
Maxwell Packe, Chairman
11 August 2021
For further information please contact:
Vikash Hansrani
Operations Partner
Albion Capital Group LLP
Telephone: 020 7601 1850
(END) Dow Jones Newswires
August 11, 2021 06:02 ET (10:02 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Albion Enterprise Vct Chart |
1 Month Albion Enterprise Vct Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions